Creative Edge Nutrition, Inc. announced that a prominent research division, Stem Cell & Tissue Proliferation, adding Dr. Jonathan Lakey as the Chief Science Officer, who will be researching initiatives in marijuana & hemp plant stem cells, plant cell cycles, tissue development acceleration, and the effects of Medical Marijuana on stem cell development including proliferation, differentiation down key developmental pathways. He is a faculty member at the Sue and Bill Gross Stem Cell Center, a CIRM funded institute focused on stem cell research focused on translating technologies into clinical practice.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 4.63K | |
+8.20% | 7.78B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-13.13% | 3.44B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
-16.45% | 802M |
- Stock Market
- Equities
- FITX Stock
- News Creative Edge Nutrition, Inc.
- Creative Edge Nutrition Inc. Appoints Dr. Jonathan Lakey as the Chief Science Officer of Stem Cell & Tissue Research